Tobacco smoking and vaping in pregnancy and neonatal outcomes: results from a UK cohort study

A UK cohort study found that while smoking and dual use of smoking and vaping during pregnancy are significantly associated with lower birthweights and longer hospital stays, vaping alone showed no such adverse neonatal outcomes, highlighting the critical importance of quitting smoking completely without reverting to it if a pregnant woman chooses to vape.

The Gist

🌱 The Big Picture: A Garden and Two Types of "Weeds"

Imagine a pregnancy is like growing a precious plant in a garden. The goal is for the baby (the plant) to grow big, strong, and healthy before it's ready to be planted in the real world (born).

For a long time, we knew that smoking cigarettes was like pouring poison on the soil. It stunts the plant's growth, making it small and weak.

But recently, a new "weed" appeared: vaping (e-cigarettes). Some people thought vaping was just a harmless mist, while others worried it might still be toxic. This study asked: If a pregnant mom uses vaping instead of smoking, does her baby grow just as well as if she used nothing at all? Or is vaping still a poison?

🔍 The Investigation: Checking the "Harvest"

Researchers in the UK looked at data from nearly 1,900 babies born recently. They asked the moms three simple questions about their pregnancy:

1. Did you smoke cigarettes?
2. Did you vape?
3. Did you do both?

They then checked the "harvest" (the baby's health) by looking at:

• Birthweight: How heavy was the baby? (Like checking if the fruit is plump or shriveled).
• Low Birthweight: Was the baby too small (under 2.5kg)?
• Hospital Stay: Did the baby need extra care in the hospital?
• Neonatal Unit: Was the baby sick enough to need a special incubator?

📊 The Findings: What the Data Showed

The researchers divided the moms into four groups, like four different teams in a race:

1. The "Clean Air" Team (Neither smoked nor vaped)

• Result: These babies were the champions. They had the highest average birthweight (about 3.31 kg). They were the "gold standard" for growth.

2. The "Vaping Only" Team

• Result: Surprisingly, these babies grew almost exactly the same size as the "Clean Air" team.
• The Analogy: Think of vaping like a harmless fog. While it's not good to have fog in your garden, the study suggests it didn't stop the plant from growing to its full size. The babies were healthy and heavy, just like the non-users.
• Note: The study didn't find a link between vaping alone and babies being born too small or needing extra hospital time.

3. The "Smoking Only" Team

• Result: This was the disaster zone. These babies were significantly smaller (about 3.00 kg) and much more likely to be born with a "low birthweight."
• The Analogy: Smoking is like pouring acid on the roots. It actively stops the plant from absorbing nutrients. The more the mom smoked, the smaller the baby tended to be.

4. The "Double Trouble" Team (Smoked AND Vaped)

• Result: These babies were also small, similar to the "Smoking Only" group.
• The Analogy: Doing both is like pouring acid on the roots AND covering the leaves in plastic. It's the worst of both worlds. Interestingly, these babies also stayed in the hospital longer than the others.

🚨 The "Dose-Response" Discovery

The study found a clear pattern with smoking: The more you smoke, the smaller the baby.

• Smoking a little bit? The baby is a bit smaller.
• Smoking every day? The baby is much smaller.
• It's like turning down the volume on a radio; the more you turn it down, the quieter the music gets.

With vaping, there was no such pattern. Whether they vaped a little or a lot, the baby's size didn't seem to change compared to non-users.

💡 What Does This Mean for Moms?

The researchers drew a very clear conclusion, which they call the "Precautionary Principle":

1. Quit Smoking Immediately: If you are pregnant and smoke, the most important thing you can do is stop. Smoking is proven to shrink babies and cause health issues.
2. Don't Swap One Poison for Another (Unless Necessary): If you are a smoker, switching to vaping is likely much safer than continuing to smoke. It's like switching from driving a car with a broken engine (smoking) to a car with a flat tire (vaping). The flat tire isn't perfect, but the broken engine is dangerous.
3. The Ideal Goal: The best outcome is to have neither smoke nor vape. If you are already a vaper and not a smoker, the advice is still to quit vaping if you can, just to be safe. But never go back to smoking cigarettes to "replace" the vape.

⚠️ A Few Caveats (The "Fine Print")

• Sample Size: There weren't many moms who only vaped (only about 2.6% of the group). It's like trying to judge the quality of a rare fruit when you only have a few samples. The study is confident about smoking, but the vaping results need more research to be 100% certain.
• Self-Report: The moms told the researchers what they did. Sometimes people forget or don't want to admit things, but the researchers tried to account for this.
• UK Regulations: This study was done in the UK, where e-cigarettes are strictly regulated (low nicotine). In countries where vapes are super strong (like some in the US), the results might be different.

🏁 The Bottom Line

Think of pregnancy as a delicate construction project.

• Smoking is like a bulldozer knocking down the walls.
• Vaping is like having a noisy construction crew next door—it's not ideal, but it doesn't seem to knock down the walls in this specific study.
• The Goal: Get the building finished strong. If you are using the bulldozer (smoking), stop immediately. If you are using the noisy crew (vaping), try to quiet them down, but do not bring the bulldozer back in.

Technical Summary

1. Problem Statement

While the adverse effects of combustible tobacco smoking during pregnancy (e.g., low birthweight, preterm birth) are well-established, there is a significant evidence gap regarding the impact of vaping (e-cigarettes) on fetal development and neonatal outcomes.

• Context: Vaping is often used as a smoking cessation tool, but its safety profile in pregnancy is unclear. Concerns exist regarding nicotine exposure and chemical byproducts, even in the absence of combustion.
• Knowledge Gap: Previous studies have been limited by small sample sizes, lack of comparison between exclusive vaping and exclusive smoking, and insufficient control for confounding variables like socioeconomic status. There is a need for robust, prospective cohort data to differentiate the risks of smoking, vaping, and dual use.

2. Methodology

Study Design & Population:

• Data Source: Secondary analysis of the UK Early Life Cohort Feasibility Study (known as "Generation New Era"), a representative birth cohort across the UK.
• Sample: Caregiver-reported data from 1,896 babies (interviewed at 9–10 months post-birth).
• Exclusion: Twins (n=82) and cases with missing primary exposure/outcome data were excluded or handled via listwise deletion (117 missing birthweight, 195 missing exposure status).
• Exposure Groups: Mothers were categorized into four mutually exclusive groups based on self-reported behavior during pregnancy:
  1. Neither: No smoking or vaping (Reference group, N=1,528).
  2. Vaping Only: Vaped but never smoked (N=44).
  3. Smoking Only: Smoked but never vaped (N=93).
  4. Dual Use: Both smoked and vaped (N=31).
• Outcomes:
  • Primary: Birthweight (kg).
  • Secondary: Low Birth Weight (LBW, <2.5kg), postnatal hospital stay duration (days), and admission to a neonatal care unit (Yes/No).
• Statistical Analysis:
  • Models: Linear regression (birthweight), Logistic regression (LBW, neonatal admission), and Negative Binomial regression (hospital stay days, due to overdispersion).
  • Adjustments: Models were adjusted for survey weights, baby sex, UK nation, Index of Multiple Deprivation (IMD), maternal age, and maternal ethnicity.
  • Sensitivity Analyses: Included dose-response assessments by frequency (occasional vs. daily), logged birthweight transformations, and substitution of household income for IMD.

3. Key Contributions

• Granular Comparison: This study is one of the first to explicitly separate exclusive vaping, exclusive smoking, and dual use in a single UK cohort, allowing for direct comparison of risks.
• Dose-Response Analysis: It provides evidence on the linear trend of smoking frequency (occasional vs. daily) regarding birth outcomes.
• Policy-Relevant Data: It addresses the specific regulatory context of the UK (where e-cigarettes are capped at 20mg/ml nicotine), offering insights distinct from markets with higher nicotine concentrations (e.g., the US).

4. Key Results

Birthweight:

• Smoking Only: Associated with a statistically significant reduction in birthweight (-0.34 kg, p<0.001) compared to the unexposed group.
• Dual Use: Associated with a significant reduction in birthweight (-0.39 kg, p=0.001).
• Vaping Only: No statistically significant difference in birthweight compared to the unexposed group (Coefficient: 0.00 kg, 95% CI: -0.14 to 0.15).
• Dose-Response: A clear dose-response relationship was found for smoking frequency; even occasional smoking was associated with lower birthweight (-0.35 kg) and increased LBW risk. No such trend was observed for vaping frequency.

Low Birth Weight (LBW):

• Smoking Only: Odds Ratio (OR) 3.96 (95% CI: 2.22–7.08) for LBW.
• Dual Use: OR 3.67 (95% CI: 1.24–10.83) for LBW.
• Vaping Only: No significant association (OR 0.54, p=0.447).

Hospital Stay & Neonatal Admission:

• Hospital Stay: Dual users had significantly longer postnatal hospital stays (+0.88 days, p=0.001). Smoking or vaping alone showed no significant association with stay duration.
• Neonatal Admission: No statistically significant differences were found across any exposure group regarding admission to neonatal care units.

Demographic Findings:

• Female babies and babies born to Asian/Asian British or Black/Black British mothers had significantly lower birthweights compared to White mothers and male babies, respectively, independent of smoking/vaping status.

5. Significance and Interpretation

• Relative Risk: The study confirms that smoking (even occasionally) and dual use are strongly associated with adverse neonatal outcomes, specifically reduced birthweight and increased LBW risk.
• Vaping Safety: In this UK cohort, exclusive vaping did not show a statistically significant association with reduced birthweight or LBW. However, the authors caution that this does not prove vaping is "safe," noting that the optimal state is zero exposure to any aerosol.
• Clinical Guidance:
  • Pregnant women should be strongly advised to quit smoking completely.
  • Women who vape should be advised to quit vaping, but not at the expense of reverting to smoking, as smoking carries substantially higher risks.
  • Dual use should be discouraged as it carries risks similar to smoking alone and is associated with longer hospital stays.
• Limitations: The study relies on self-reported data (potential for recall bias), has limited power for the small vaping/dual-use subgroups, and lacks objective biomarkers (e.g., cotinine levels) or gestational age data to distinguish between preterm birth and fetal growth restriction.
• Generalizability: Findings apply to the UK context (20mg/ml nicotine limit). Results may differ in countries with higher nicotine concentrations in e-liquids.

Conclusion: The study reinforces the critical importance of smoking cessation during pregnancy. While vaping appears less harmful than smoking regarding birthweight in this dataset, the precautionary principle suggests pregnant women should avoid vaping, provided they do not return to combustible tobacco.